已收录 268921 条政策
 政策提纲
  • 暂无提纲
Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonist
[摘要] The discovery of a novel 3H-pyrido[2,3-d]pyrimidin-4-one series as potent and biased sst2 agonists is described. This class of molecules exhibits excellent sst2 potency and selectivity against sst1, sst3, and sst5 receptors, and they are significantly more potent at inhibiting cAMP production than inducing internalization. The orally bioavailable 6-(3-chloro-5-methylphenyl) 3 (3 fluoro-5-hydroxyphenyl)-5-amethyl[(2S)-pyrrolidin-2-ylmethyl] amino}methyl)-3H,4H-pyrido[2,3-d]pyrimidin-4-one (36) also suppresses GH secretion in GHRH-challenged rats in a dose-dependent manner.
[发布日期] 2020-11-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Somatostatin;sst2 agonist;Acromegaly;Growth hormone (GH);3H-pyrido [2, 3-d] pyrimidin-4-one [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文